Fixed Drug Eruption Induced by Griseofulvin
نویسندگان
چکیده
منابع مشابه
Fixed drug eruption induced by atenolol
Fixed drug eruption (FDE) is characterized by recurrent well-defined lesions in the same location each time the responsible drug is taken. We report here a case of multiple FDE induced by atenolol in a 48-year-old woman confirmed by positive patch test in previously affected sites. Beta-blockers-induced FDE are very rare. Only two cases had been reported in the literature. To the best of our kn...
متن کاملNimesulide-induced fixed drug eruption.
BACKGROUND Nimesulide is a cyclooxygenase (COX) inhibitor with a high degree of selectivity to COX-2. It is a widely used and well tolerated nonsteroidal antiinflammatory drug that also has analgesic and antipyretic properties. The most frequently reported side effects concern the gastrointestinal tract. Pruritus and skin rash are the most common cutaneous adverse reactions. There are only eigh...
متن کاملFluconazole Induced Fixed Drug Eruption
We report on a rare case of fluconazole induced fixed drug eruption in a 62-year old female patient. She was referred to our department for multiple erythematous itchy maculopatches on the face, neck, both upper arms, and trunk area, which had occurred over the previous 6 months. Her attending physician prescribed fluconazole for treatment of onychomycosis. Patch test and oral provocation were ...
متن کاملCiprofloxacin-induced generalized bullous fixed drug eruption.
1. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: The clinical, histological and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990;70:165-71. 2. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;91:431-6. 3. Van der Meij E...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Dermatology
سال: 1989
ISSN: 1018-8665,1421-9832
DOI: 10.1159/000248322